BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa —a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings

DiscussionThe second site for the implementation of this protocol has changed from Tanzania to Kenya. This summary presents the Mozambique-specific protocol while the updated master protocol and the adapted Kenya-specific protocol undergo national approval in Kenya. BOHEMIA will be the first large-scale trial evaluating the impact of ivermectin-only mass drug administration to humans or humans and cattle on local malaria transmissionTrial registrationClinicalTrials.govNCT04966702. Registered on July 19, 2021.Pan African Clinical Trials Registry PACTR202106695877303.
Source: Trials - Category: Research Source Type: clinical trials